4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000477
Chief Executive Officer bought 100,000 shares at $2.50 ($250,000)
From the SEC's structured data for this filing
Trades in this filing
COLA MICHAEL F · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-09 | Purchase : show line 1 in the form | +100,000 | $2.50 | $250,000 | 175,746 | D |
| Open-market purchases · 100,000 sh · avg $2.50 · $250,000 | ||||||
Loading xslF345X03/edgar.xml…